Mutual of America Capital Management LLC lowered its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 290,163 shares of the company’s stock after selling 7,757 shares during the quarter. Procter & Gamble comprises about 0.5% of Mutual of America Capital Management LLC’s holdings, making the stock its 22nd biggest holding. Mutual of America Capital Management LLC’s holdings in Procter & Gamble were worth $50,256,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently bought and sold shares of PG. Acorn Creek Capital LLC lifted its position in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its stake in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares in the last quarter. Hudson Value Partners LLC raised its holdings in Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the last quarter. Traveka Wealth LLC grew its holdings in Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after purchasing an additional 60 shares during the last quarter. Finally, Fiduciary Alliance LLC raised its stake in shares of Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after buying an additional 61 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
Shares of NYSE:PG opened at $169.54 on Friday. The firm has a market capitalization of $399.27 billion, a PE ratio of 29.23, a P/E/G ratio of 3.67 and a beta of 0.42. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The business has a 50-day moving average of $170.32 and a two-hundred day moving average of $168.36.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.
Wall Street Analysts Forecast Growth
PG has been the subject of several recent research reports. JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. DA Davidson lifted their price objective on Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research report on Monday, October 21st. Stifel Nicolaus raised their price target on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, Evercore ISI increased their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $177.00.
View Our Latest Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 25.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 31,797 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the sale, the chief executive officer now owns 300,777 shares in the company, valued at $50,897,483.94. This represents a 9.56 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 313,597 shares of company stock worth $53,268,499. Corporate insiders own 0.18% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- What is a buyback in stocks? A comprehensive guide for investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Which Wall Street Analysts are the Most Accurate?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Use the MarketBeat Excel Dividend Calculator
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.